CHARITE™ vs. ALIF 5-Year Follow-up
Five-year Follow-up of the CHARITÉ™ Artificial Disc Compared to Anterior Lumbar Interbody Fusion With the BAK Cage.
1 other identifier
observational
367
1 country
10
Brief Summary
To assess the clinical and radiographic outcomes through 5-years following treatment with CHARITÉ™ Artificial Disc vs. the BAK Cage for treatment of degenerative disc disease at one level (L4-S1).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2005
Typical duration for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 22, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedApril 13, 2015
April 1, 2015
September 14, 2005
April 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Success
ODI Improvement greater than or equal to 15 points from baseline No device failures (i.e., revision, re-operation, supplemental fixation, or removal) No major complications Maintenance or improvement in neurological status compared to baseline.
5 Years
Secondary Outcomes (1)
Secondary Endpoints
5 Years
Study Arms (3)
Training- CHARITE
Non-Randomized Training (TDR with CHARITE)
CHARITE
Randomized Subjects treated by Lumbar Total Disc Replacment with CHARITE
Control
Randomized Subjects treated by ALIF with BAK cage
Interventions
Eligibility Criteria
You may qualify if:
- Participated in either the training or randomized arm of the CHARITÉ Artificial Disc IDE study,
- Still have the original implant they received in their index surgery.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- DePuy Spinelead
Study Sites (10)
Charite Site 13
Los Angeles, California, 90048, United States
Charite Site 06
Golden, Colorado, 80401, United States
Charite Site 11
Chicago, Illinois, 60640, United States
Charite Site 03
Louisville, Kentucky, 40202, United States
Charite Site 02
Towson, Maryland, 21204, United States
Charite Site 15
Boston, Massachusetts, 02120, United States
Charite Site 14
Lockport, New York, 14094, United States
Charite Site 10
New York, New York, 10003, United States
Charite Site 07
Columbus, Ohio, 43214, United States
Charite Site 01
Plano, Texas, 75093, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Daniel H Stoutenburgh
DePuy Spine
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 22, 2005
Study Start
March 1, 2005
Study Completion
July 1, 2007
Last Updated
April 13, 2015
Record last verified: 2015-04